Breaking News Bar

Business News and Information

Johnson & Johnson posts strong third quarter earnings after pause in coronavirus vaccine study

Johnson & Johnson reported a strong third quarter performance on Tuesday following an announcement that it is pausing its coronavirus vaccine research study.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear